Jacoby R

References (6)

Title : Donepezil and memantine for moderate-to-severe Alzheimer's disease - Howard_2012_N.Engl.J.Med_366_893
Author(s) : Howard R , McShane R , Lindesay J , Ritchie C , Baldwin A , Barber R , Burns A , Dening T , Findlay D , Holmes C , Hughes A , Jacoby R , Jones R , McKeith I , Macharouthu A , O'Brien J , Passmore P , Sheehan B , Juszczak E , Katona C , Hills R , Knapp M , Ballard C , Brown R , Banerjee S , Onions C , Griffin M , Adams J , Gray R , Johnson T , Bentham P , Phillips P
Ref : N Engl J Med , 366 :893 , 2012
Abstract : Howard_2012_N.Engl.J.Med_366_893
ESTHER : Howard_2012_N.Engl.J.Med_366_893
PubMedSearch : Howard_2012_N.Engl.J.Med_366_893
PubMedID: 22397651

Title : Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial) - Ballard_2009_Am.J.Geriatr.Psychiatry_17_726
Author(s) : Ballard C , Brown R , Fossey J , Douglas S , Bradley P , Hancock J , James IA , Juszczak E , Bentham P , Burns A , Lindesay J , Jacoby R , O'Brien J , Bullock R , Johnson T , Holmes C , Howard R
Ref : American Journal of Geriatry & Psychiatry , 17 :726 , 2009
Abstract : Ballard_2009_Am.J.Geriatr.Psychiatry_17_726
ESTHER : Ballard_2009_Am.J.Geriatr.Psychiatry_17_726
PubMedSearch : Ballard_2009_Am.J.Geriatr.Psychiatry_17_726
PubMedID: 19700946

Title : DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT - Jones_2009_Trials_10_57
Author(s) : Jones R , Sheehan B , Phillips P , Juszczak E , Adams J , Baldwin A , Ballard C , Banerjee S , Barber B , Bentham P , Brown R , Burns A , Dening T , Findlay D , Gray R , Griffin M , Holmes C , Hughes A , Jacoby R , Johnson T , Knapp M , Lindesay J , McKeith I , McShane R , Macharouthu A , O'Brien J , Onions C , Passmore P , Raftery J , Ritchie C , Howard R
Ref : Trials , 10 :57 , 2009
Abstract : Jones_2009_Trials_10_57
ESTHER : Jones_2009_Trials_10_57
PubMedSearch : Jones_2009_Trials_10_57
PubMedID: 19630974

Title : Donepezil for the treatment of agitation in Alzheimer's disease - Howard_2007_N.Engl.J.Med_357_1382
Author(s) : Howard RJ , Juszczak E , Ballard CG , Bentham P , Brown RG , Bullock R , Burns AS , Holmes C , Jacoby R , Johnson T , Knapp M , Lindesay J , O'Brien JT , Wilcock G , Katona C , Jones RW , DeCesare J , Rodger M
Ref : N Engl J Med , 357 :1382 , 2007
Abstract : Howard_2007_N.Engl.J.Med_357_1382
ESTHER : Howard_2007_N.Engl.J.Med_357_1382
PubMedSearch : Howard_2007_N.Engl.J.Med_357_1382
PubMedID: 17914039

Title : Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial - Ballard_2005_BMJ_330_874
Author(s) : Ballard C , Margallo-Lana M , Juszczak E , Douglas S , Swann A , Thomas A , O'Brien J , Everratt A , Sadler S , Maddison C , Lee L , Bannister C , Elvish R , Jacoby R
Ref : BMJ , 330 :874 , 2005
Abstract : Ballard_2005_BMJ_330_874
ESTHER : Ballard_2005_BMJ_330_874
PubMedSearch : Ballard_2005_BMJ_330_874
PubMedID: 15722369

Title : Treating the dementia of Iris with a cholinesterase inhibitor -
Author(s) : Jacoby R
Ref : Int J Geriatr Psychiatry , 18 :756 , 2003
PubMedID: 12891646